Notably, pathways related to hematopoietic cell lineage, intestinal immune network for immunoglobulin A (IgA) production, and toll-like receptor signaling were found to be upregulated in the AM patients. This evidence concerns the gene CD79A and acute myeloblastic leukemia with maturation.